Skip to main content

UBS Group AG

Position in AUTL — Autolus Therapeutics plc

CIK 1610520 ZURICH, V8

Position in AUTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,427,184
+$625,211 QoQ
Shares Held
1,516,991
+16.2% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in AUTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. AUTL ranks #201 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUTL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,427,184 1,516,991
2026-03-31 $1,801,973 1,305,779
2025-12-31 $1,745,428 877,100
2025-09-30 $669,378 410,662
2025-06-30 $806,359 353,667
2025-03-31 $490,150 316,227
2024-12-31 $470,544 200,232
2024-09-30 $569,829 156,978
2024-06-30 $472,551 135,791
2024-03-31 $592,369 92,848
2023-12-31 $545,177 84,655
2023-09-30 $191,781 82,310
2023-06-30 $166,820 70,093
2023-03-31 $118,434 64,367
2022-12-31 $32,297 16,999
2022-09-30 $89,397 41,775
2022-06-30 $119,065 42,073
2022-03-31 $307,987 73,858
2021-12-31 $46,969 9,050
2021-09-30 $49,092 7,495
2021-06-30 $106,777 16,081
2021-03-31 $107,231 18,714
2020-12-31 $49,563 5,544
2020-09-30 $37,934 3,259
2020-06-30 $78,514 4,898
2020-03-31 $19,365 3,233